Market Live Email

Molten Ventures expects to report 'sharp rise' in both NAV and GPV, AstraZeneca's Saphnelo receives US FDA approval

By Iain Gilbert

Date: Monday 27 Apr 2026

(Sharecast News) - LONDON PRE-OPEN

The FTSE 100 was expected to open just 0.3 points higher ahead of the bell on Monday, after wrapping up the previous session 0.75% lower at 10,379.08.


STOCKS TO WATCH

Venture capital firm Molten Ventures said on Monday that it expects...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page